Polymorbidity and indicators of carbohydrate, lipid and purine metabolism in patients with arterial hypertension
https://doi.org/10.18699/SSMJ20210406
Abstract
Aim of the study was to investigate the peculiarities of the relationship of polymorbid pathology in arterial hypertension with disorders of lipid, purine and carbohydrate metabolism. Material and methods. Patients with arterial hypertension with the presence of polymorbid pathology, who underwent examination and treatment at the clinic of the Federal Research Center for Fundamental and Translational Medicine (Novosibirsk), were examined. A total of 9775 people were examined. The patients were divided into 2 groups: with arterial hypertension in the dyslipidemia absence (n = 561(252 men (44.9 %), 309 women (55.1 %), average age 57.1 ± 0.60 years) and in the dyslipidemia presence (n = 9214 (3879 (42.1 %) men, 5335 (57.9 %) women, average age 57.82 ± 0.12 years). Results and discussion. Hyperglycemia and hyperuricemia were more common in patients with arterial hypertension with dyslipidemia; the indicators were statistically higher: total serum cholesterol, low-density lipoprotein cholesterol, triglycerides, atherogenic index, serum glucose, uric acid compared with patients with arterial hypertension without dyslipidemia. In patients with dyslipidemia, compared with patients without dyslipidemia, arterial hypertension was more often combined with diseases of the endocrine system, nutritional disorders and metabolic disorders, and other diseases of the circulatory system. Conclusion. The data obtained can serve as a theoretical basis for the concept of care for polymorbid patients, based on the impact on the main key pathogenetic mechanisms of diseases, and new approaches to complex treatment, rehabilitation and personalized prevention, taking into account the impact on modifiable risk factors.
About the Authors
Yu. A. Nikolaev
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Yuri A. Nikolaev, doctor of medical sciences
630117, Novosibirsk, Timakov str., 2
V. Ya. Polyakov
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Vladimir Ya. Polyakov, doctor of medical sciences
630117, Novosibirsk, Timakov str., 2
I. M. Mitrofanov
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Igor M. Mitrofanov, doctor of medical sciences
630117, Novosibirsk, Timakov str., 2
E. V. Sevostyanova
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Evgeniya V. Sevostyanova, candidate of medical sciences
630117, Novosibirsk, Timakov str., 2
I. I. Kovrigin
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Igor I. Kovrigin
630117, Novosibirsk, Timakov str., 2
References
1. Violan C., Foguet-Boreu Q., Flores-Mateo G., Salisbury Ch., Blom J., Freitag M., Glynn L., Muth C., Valderas J.M. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014; 9 (7): 102149. doi: 10.1371/journal.pone.0102149
2. Roberts K.C., Rao D., Bennett T.L., Loukine L., Jayaraman G.C. Prevalence and patterns of chronic disease multimorbidity and associated determinants in Canada. Health Promot. Chronic Dis. Prev. Can. 2015; 35 (6): 87-94. doi: 10.24095/hpcdp.35.6.01
3. Belyalov F.I. Treatment of internal diseases in terms of comorbidity. Moscow: GEOTAR-Media, 2016: 544 p. [In Russian].
4. Nikolaev Yu.A., Sevost’yanova E.V., Mitrofanov I.M., Polyakov V.Ya., Dolgova N.A. Features of polymorbidity in patients of the therapeutic clinic of cardiological and gastroenterological profile. Terapevticheskij arhiv = Therapeutic Archive. 2016; (1): 40- 45. [In Russian]. doi: 10.17116/terarkh201688140-45
5. Ahmadi B., Alimohammadian M., Yaseri M., Majidi A., Boreiri M., Islami F., Poustchi H., Derakhshan M.H., Feizesani A., Pourshams A., Abnet C.C., Brennan P., Dawsey S.M., Kamangar F., Boffetta P., Sadjadi A., Malekzadeh R. Multimorbidity: epidemiology and risk factors in the Golestan Cohort Study, Iran: A cross-sectional analysis. Medicine (Baltimore). 2016; 95 (7): e2756. doi: 10.1097/MD.0000000000002756
6. World Health Organization. Noncommunicable Diseases Country Profiles 2011. Geneva: WHO Press; 2011. 209 p.
7. Ferretti F. Unhealthy behaviours: an international comparison. PLoS One. 2015; 10 (10): 1–14. doi: 10.1371/journal.pone.0141834. eCollection 2015
8. Oganov R.G., Komarov Ju.M., Maslennikova G.S. Demographic problems as a mirror of the nation’s health. Profilakticheskaja meditsina = Preventive Medicine. 2009; 12 (2): 3–8. [In Russian].
9. European clinical guidelines for the prevention of cardiovascular diseases (2016 revision). Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2017; 146 (6): 7-85. [In Russian]. doi: 10.15829/1560-4071-2017-6-7-85
10. Brown I.A.M., Diederich L., Good M.E., DeLalio L.J., Murphy S.A., Cortese-Krott M.M., Hall J.L., Le T.H., Isakson B.E. Vascular smooth muscle remodeling in conductive and resistance arteries in hypertension. Arterioscler. Thromb. Vasc. Biol. 2018; 38 (9): 1969-1985. doi: 10.1161/ATVBAHA.118.311229
11. Russian Society of Cardiology. Arterial hypertension in adults. Clinical guidelines 2020. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25 (3): 149-218. [In Russian]. doi: 10.15829/1560-4071-2020-3-3786
12. European Society of Hypertension-European Society of Cardiology Guidelines Commitee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the managment of arterial hypertension. J. Hypertension. 2003; 21 (6): 1011-1053. doi: 10.1097/00004872-200306000-00001
13. Sum G., Salisbury C., Koh G.C., Atun R., Oldenburg B., McPake B., Vellakkal S., Lee J.T. Implications of multimorbidity patterns on health care utilization and quality of life in middle-income countries: cross-sectional analysis. J. Glob. Health. 2019; 9 (2): 020413. doi: 10.7189/jogh.09.020413
14. Nikolaev Ju.A., Gevorgjan M.M., Kozaruk T.V., Kuznetsova A.P., Poljakov V.Ja. Features of clinicalbiochemical and immunological indicators in patients with arterial hypertension, newcomers from the North, combined with diseases of the hepatobiliary system. Byulleten’ Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk = Bulletin of Siberian Branch of Russian Academy of Medical Sciences. 2012; 32 (4): 66-71. [In Russian].
15. Belousov Yu.V. Comorbidity in diseases of the digestive system of children. Zdorov’e rebenka = Child. Health. 2012; (1): 134–136. [In Russian].
16. Chesnikova A.I., Batyushin M.M., Terent’ev V.P. Arterial hypertension and comorbidity: current state of the problem. Arterial’naya gipertenziya = Arterial Hypertension. 2016; 22 (5): 432–440. [In Russian]. doi: 10.18705/1607-419X-2016-22-5-432-440
17. Ageev F.T. The role of endothelial dysfunction in the development and progression of cardiovascular diseases. Serdechnaya nedostatochnost’ = Russian Heart Failure Journal. 2003; (1): 22–25. [In Russian].
18. Jushhuk E.N., Vasjuk Ju.A., Hadzegova A.B., Filippov P.G., Ivanova S.V., Shkol’nik E.L., Kulikov K.G., Dudarenko O.P. Endothelial dysfunction in diseases of the cardiovascular system and methods of its correction. Klinicheskaya farmakologiya i terapiya = Clinical Pharmacology and Therapy. 2005; 14 (3): 85–88. [In Russian].
19. Born G., Schwartz C. Vascular endothelium. Stuttgart: Schattauer, 1997. 390 p.
20. Ragino Ju.I., Chernjavskij A.M., Polonskaja Ja.V., Volkov A.M., Kashtanova E.V. The content of proinflammatory cytokines, chemoattractants and destructive metalloproteinases in different types of unstable atherosclerotic plaques. Ateroskleroz i dislipidemii = The Journal of Atherosclerosis and Dyslipidemias. 2011; (1): 23–27. [In Russian].
21. Pospelova L.M., Sorokoumov V.A., Beljakova L.A. To the question of the possibility of clarifying the tactics of treatment of atherosclerotic lesions of brachiocephalic arteries using laboratory diagnostics. Uspekhi sovremennogo yestestvoznaniya = Advances in Current Natural Sciences. 2014; 12 (3): 186–190. [In Russian].
22. Fateeva A.A., Unerbaeva S.A., Il’malieva A.Zh., Petunina N.A. Immuno-inflammatory reactions in patients with comorbid thyroid disease and metabolic syndrome (complete and incomplete metabolic syndrome). Sovremennaya nauka: aktual’nyye problemy teorii i praktiki. Seriya: Yestestvennyye i tekhnicheskiye nauki = Modern Science: Topical Problems of Theory and Practice. Series: Natural and Technical Sciences. 2016; 9–10: 77–81. [In Russian].
23. Sapozhnikov A.N., Leonova E.Je., Jahina G.H., Danilova K.S. Pathology of the endocrine system as a risk factor for «acute coronary syndrome without St segment elevation» in poorly modified coronary arteries. Mezhdunarodnyy zhurnal serdtsa i sosudistykh zabolevaniy = International Heart and Vascular Disease Journal. 2017; 5 (13): 23–29. [In Russian].
24. Vovk K.V., Nikolenko E.Ja., Sokruto O.V., Vlasenko O.A., Kratenko A.S., Martynenko M.V., Aleksandrova N.K., Laricheva L.V., Kandyba V.P., Letik I.V. The need for statins in patients with hypothyroidism: pros and cons. Br. Med. Bull. 2018; 128 (1): 209–215. [In Russian].
25. Gusova Z.R., Dzantieva E.O. The role of visceral obesity and testosterone deficiency in the formation of metabolic disorders in men. Vestnik urologii = Urology Bulletin. 2019; 7 (3): 14–22. [In Russian]. doi: 10.21886/2308-6424-2019-7-3-14-22
Review
Views:
324
Email this article 